Portfolio company
Cytos Biotechnology AG
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biopharmaceutical company develops immunotherapies and vaccines targeting chronic and infectious diseases for patients and healthcare providers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Pharmexa A/S
This company develops active immunotherapy and peptide vaccines for patients with cancer, chronic illnesses, and infectious diseases.
Hookipa Pharma
This biopharmaceutical company develops arenavirus-based immunotherapies to treat infectious diseases and cancers for patients and healthcare providers.
immunos
This biotechnology company develops immunomodulatory proteins and HLA-based biologic therapies for pharmaceutical companies and healthcare providers to treat cancer and autoimmune diseases.
GlycoVaxyn
This biotechnology company develops bioconjugate vaccines for pharmaceutical partners to prevent and treat bacterial infections.
Barinthus Biotherapeutics
This biopharmaceutical company develops antigen-specific immunotherapies and vaccines to treat patients with chronic infectious diseases, autoimmunity and cancer.
Apini Therapeutics
This biotechnology company develops small molecule compounds to treat chronic inflammatory diseases for healthcare providers and patients.
Vaccitech Ltd
This biopharmaceutical company develops immunotherapeutic products and vaccines for patients with chronic infectious diseases, autoimmune conditions and cancer.
Abacus Bioscience
This company develops active immunotherapies to treat cancer and chronic infections for patients requiring advanced medical treatments.
